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Background  :  Community-acquired  pneumonia  (CAP)  remains  a  common  and  serious  condition  worldwide.  The 
mortality  from  severe  CAP  remains  high,  and  this  has  reached  50%  in  some  series.  This  study  was  conducted  to 
determine  the  mortality  and  predictors  that  contribute  to  in-hospital  mortality  for  patients  who  exhibit  CAP  and  acute 
respiratory  failure  that  requires  mechanical  ventilation. 
Methods  :  We  retrospectively  reviewed  the  medical  records  of  85  patients  with  severe  CAP  as  a  primary  cause 
of  acute  respiratory  failure,  and  this  required  mechanical  ventilation  in  a  setting  of  the  medical  intensive  care  unit  (ICU) 
of  a  tertiary  university  hospital  between  2000  and  2003. 
Results  :  The  overall  in-hospital  mortality  was  56%  (48/85).  A  Cox-proportional  hazard  model  revealed  that  the 
independent  predictive  factors  of  in-hospital  mortality  included  a  PaCO2  of  less  than  45  mmHg  (p<0.001,  relative  risk 
[RR]:  4.73;  95%  confidence  interval  [CI]:  2.16-10.33),  a  first  24-hour  urine  output  of  less  than  1.5  L  (p=0.006,  RR:  2.46, 
95%  CI:  1.29-4.66)  and  a  high  APACHE  II  score  (p=0.004,  RR:  1.09,  95%  CI:  1.03-1.16). 
Conclusions  :  Acute  respiratory  failure  caused  by  severe  CAP  and  that  necessitates  mechanical  ventilation  is 
associated  with  a  high  mortality  rate.  Initial  hypercapnia  and  a  large  urine  output  favored  survival,  whereas  a  high 
APACHE  II  score  predicted  mortality.
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INTRODUCTION
Community-acquired  pneumonia  (CAP)  is  among  the  most 
frequent  causes  of  hospitalization,  and  it  is  one  of  the  most 
common  causes  of  admission  to  intensive  care  units  (ICUs)
1, 2). 
Despite  the  advances  in  antibiotic  therapy  and  supportive 
measures,  the  mortality  rate  for  patients  with  severe  pneumonia 
that  requires  admission  to  an  ICU  remains  high,  ranging  from 
29%  to  55%
3-7).
The  most  important  risk  factors  for  mortality  include  an 
advanced  age,  multilobar  consolidation,  respiratory  failure, 
mechanical  ventilation,  shock,  bacteremia,  renal  failure,  an 
altered  mental  status,  inadequate  antimicrobial  therapy  and  a 
high  acute  physiology  and  chronic  health  evaluation  (APACHE) 
II  score
3-7).  Many  prognostic  factors  have  been  studied  in 
different  subpopulations,  and  the  requirement  for  mechanical 
ventilation  is  known  to  be  associated  with  increased  mortality
3-5). 
However,  the  prognostic  factors  for  mortality  have  not  been  well 
investigated  among  the  subgroup  of  patients  who  require 
mechanical  ventilation
8).  Therefore,  it  is  uncertain  whether  the 
prognostic  criteria  derived  from  mixed  populations  of  ventilated 
and  nonventilated  patients  are  relevant  for  those  specific 
patients  who  require  mechanical  ventilation.  The  rules  that 
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Variable
All  patients
(n=85)
Survivors
(n=37)
Non-survivors
(n=48) p  value
Age  (years)
Male  gender
Systolic  blood  pressure  (mmHg)
Diastolic  blood  pressure  (mmHg)
Mean  blood  pressure  (mmHg)
Pulse  rate  (/min)
Respiratory  rate  (/min)
Body  temperature  (℃)
Preexisting  comorbidity
    Diabetes  Mellitus
    Hypertension
    Ischemic  heart  disease
    Atrial  fibrillation
    Congestive  heart  failure
    Bronchial  asthma
    COPD
    Tuberculous  destroyed  lung
    Bronchiectasis
    Neurologic  disease
    Alcoholics
    Liver  cirrhosis
    Malignancy
    Systemic  lupus  erythematosis
APACHE  II
Glasgow  coma  scale
First  24-hour  urine  output,  L/day
    ≥ 1.5  L
68.7±13.0
61  (72)
124±34
72±22
89±25
109±24
29±9
36.9±0.9
23  (27)
16  (19)
12  (14)
9  (11)
4  (5)
4  (5)
19  (22)
13  (15)
5  (6)
11  (13)
6  (7)
2  (2)
4  (5)
3  (4)
19.1±6.1
11.5±2.5
1676±1001
42  (49)
67.0±13.9
24  (65)
129±32
75±20
92±23
110±23
29±9
36.8±0.8
12  (32)
6  (16)
5  (14)
4  (11)
1  (3)
1  (3)
9  (24)
5  (14)
1  (3)
6  (16)
0  (0)
0  (0)
0  (0)
1  (3)
18.4±5.7
12.0±2.2
2023±1073
25  (68)
70.0±12.3
37  (77)
120±36
69±24
87±27
109±25
29±10
37.0±1.0
11  (23)
10  (21)
7  (15)
5  (10) 
3  (6)
3  (6)
10  (21)
8  (17)
4  (8)
5  (10)
6  (13)
2  (4)
4  (8)
2  (4)
19.7±6.4
11.0±2.7
1401±869
17  (35)
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
0.026
NS
NS
NS
NS
NS
0.004
0.003
1Data  are  No.  (%)  or  means±SDs. 
NS,  not  significant;  COPD,  chronic  obstructive  pulmonary  disease;  APACHE  II,  Acute  Physiology  and  Chronic  Health  Evaluation  II.
Table  1.  Baseline  characteristics  of  the  patients  with  severe  pneumonia
1
adequate  to  identify  the  majority  of  patients  with  severe  CAP 
and  to  provide  useful  support  for  the  decision-making  process. 
They  may  also  contribute  to  the  evaluation  process  and 
determining  the  outcomes  of  care  for  CAP  patients,  and  they 
allow  for  better  patient  and  patient  family  counseling
9).
The  objectives  of  this  study  were  to  determine  the  mortality 
and  the  relative  importance  of  many  factors  that  influence  the 
survival  of  mechanically  ventilated  patients  with  severe  CAP, 
and  these  factors  include  the  baseline  characteristics  at 
admission  and  the  organ  failure  that  develops  over  the  course 
of  mechanical  ventilation. 
MATERIALS AND METHODS
Patient  selection
We  retrospectively  evaluated  the  consecutive  patients  with 
severe  CAP  and  who  required  mechanical  ventilation  at 
admission  or  on  the  day  following  admission  to  the  ICU  at 
Ewha  Womans  University  Hospital  from  January  1,  2000  through 
December  31,  2003.  Those  patients  who  had  been  pretreated 
before  admission,  those  who  had  other  causes  of  respiratory 
failure,  those  who  were  suspected  of  having  nosocomial 
pneumonia  or  those  who  died  within  24  hours  of  admission 
were  excluded.  Finally,  85  patients  were  included.  The  main 
outcome  was  hospital  mortality.  The  clinical  and  laboratory 
characteristics  at  admission  and  during  the  course  of 
mechanical  ventilation  were  compared  between  the  survivors 
and  non-survivors.  The  selection  of  these  variables  was  based 
on  clinical  experience  and  on  a  review  of  the  published  data
3-8).
Definitions
CAP  was  defined  as  an  acute  respiratory  illness  acquired  in 
a  non-hospital  setting  and  it  was  manifested  by  characteristic 
symptoms  (cough,  sputum,  dyspnea,  pleuritic  chest  pain  and/or 
an  altered  mental  status)  with  the  appearance  of  a  new 
compatible  radiographic  infiltrate,  accompanied  by  fever  (>38.5℃) 
or  hypothermia  (<36.0℃),  and/or  an  abnormally  increased  or 
decreased  white  blood  cell  (WBC)  count
10).  Severe  CAP  was 
defined  as  pneumonia  that  required  mechanical  ventilation  for 
one  or  more  of  the  following  reasons:  hypoxemic  respiratory 
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Variable
All  patients
(n=85)
Survivors
(n=37)
Non-survivors
(n=48)
p  value
Arterial  pH
PaO2  (mmHg)
PaCO2  (mmHg)
    ≥45  mmHg
D(A-a)O2  (mmHg)
PaO2/FiO2  (mmHg)
Haemoglobin  (g/L)
Hematocrit  (%)
White  cell  counts  (×10
9/L)
Platelet  counts  (×10
9/L)
ESR  (mm/h)
C-reactive  protein  (mg/dL)
Blood  urea  nitrogen  (mg/dL)
Creatinine  (mg/dL)
Glucose  (mg/dL)
Albumin  (g/dL)
    ≥4  g/dL
Total  bilirubin  (mg/dL)
Sodium  (mmol/L)
Potassium  (mmol/L)
7.36±0.14
53.2±19.3
41.2±19.9
28  (33)
68.2±103.1
238±87
119±20
35.1±6.3
13.7±7.4
249±165
41±33
14.6±11.4
29.0±21.5
1.35±1.15
182±99
3.0±0.6
4  (5)
1.0±2.0
137±6
4.4±0.8
7.34±0.12
49.2±16.6
48.7±23.0
19  (51)
39.7±30.3
234±79
122±19
36.2±5.8
15.4±8.6
280±179
39±33
15.4±14.2
24.7±17.7
1.11±0.87
192±117
3.1±0.7
4  (11)
0.9±1.2
138±6
4.3±0.6
7.38±0.15
56.3±20.9
35.5±15.0
9  (19)
90.1±131.0
241±94
117±20
34.2±6.6
12.4±6.1
226±152
44±33
14.0±8.9
32.3±23.6
1.54±1.31
174±82
2.8±0.6
0  (0)
1.1±2.5
137±6
4.5±1.0
NS
NS
0.004
0.002
0.013
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
0.049
0.021
NS
NS
NS
1Data  are  No.  (%)  or  means±SDs. 
NS,  not  significant;  ESR,  erythrocyte  sedimentation  rate.
Table  2.  Laboratory  characteristics  of  the  survivors  and  non-survivors  with  severe  pneumonia  at  admission
1
supplemental  oxygen),  hypercarbic  respiratory  failure  (a  pH  < 
7.25  with  a  PaCO2  >  50  mmHg)  or  an  inability  to  protect  the 
airway  due  to  a  depressed  mental  status.  All  the  patients  were 
investigated  using  an  acute  physiology  and  chronic  health 
evaluation  (APACHE)  II  questionnaire
11).
Statistical  Analysis
Mean  values  and  standard  deviations  were  used  to 
summarize  the  results  of  the  continuous  variables,  and  numbers 
and  percentages  were  used  to  summarize  the  results  for  the 
categorical  data.  All  the  statistical  results  were  produced  using 
SPSS-PC  (version  11.0,  SPSS  Inc,  Chicago,  IL).  Independent 
two  group  comparisons  were  performed  using  the  Student 
t-test,  and  the  χ
2  test  was  used  to  compare  the  categorical 
variables.  We  used  Cox  regression  analysis  for  the  survival 
analysis,  and  the  relative  risks  and  95%  confidence  intervals  (CI) 
were  calculated.  All  the  reported  p  values  are  two  sided,  and  p 
values  <  0.05  were  considered  statistically  significant.
RESULTS
Among  the  85  patients  with  pneumonia,  48  died  for  a 
mortality  rate  of  56%.  At  admission,  no  differences  were 
observed  between  the  survivors  and  non-survivors  in  terms  of 
age,  gender  and  the  vital  signs.  However,  alcoholics  were  less 
common  among  the  survivors  than  the  non-survivors  (p=0.026). 
The  survivors  had  a  significantly  larger  first  24-hour  urine  output 
than  did  the  non-survivors  (p=0.004),  and  the  survivors  had  a 
lower  APACHE  II  score,  though  this  was  not  statistically 
significant  (Table  1). 
Arterial  blood  gas  analyses  showed  that  the  survivors  had  a 
significantly  higher  PaCO2  (p=0.004)  and  lower  alveolar-arterial 
oxygen  differences  [D(A-a)O2]  than  did  the  non-survivors 
(p=0.013),  and  the  serum  albumin  level  was  higher  in  the 
survivors  than  that  in  the  non-survivors  (p=0.049)  (Table  2). 
The  microbiologic  results  showed  no  difference  between  the 
survivors  and  non-survivors.  Streptococcus  pneumoniae  was  the 
most  commonly  isolated  respiratory  pathogen  and  Pseudomonas 
aeruginosa  and  methicillin-resistant  Staphylococcus  aureus  were 
the  next  2  most  common  pathogens.
No  difference  was  evident  between  the  survivors  and  non- 
survivors  in  terms  of  the  time  to  start  administering  antibiotics. 
The  initial  antibiotic  of  choice  was  similar  for  the  two  groups, 
except  for  vacomycin/teicoplanin,  which  was  more  commonly 
given  to  the  survivor  group  (p=0.02). 
For  the  survivors,  the  number  of  days  requiring  endotracheal 
intubation  (p=0.029)  and  mechanical  ventilation  were  significantly 
less  than  that  for  the  non-survivors  (p=0.019).  During 
hospitalization,  a  significantly  lower  incidence  of  gastrointestinal 
bleeding  was  noted  for  the  survivors  (p=0.001)  (Table  3).
Cox  regression  survival  analyses  showed  that  a  PaCO2  of 
less  than  45  mmHg  (p<0.001,  relative  risk  [RR]=4.73,  95% 
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Variable
Total
(n=85)
Survivors
(n=37)
Non-survivors
(n=48)
p  value
Length  of  intubation  (days)
Duration  of  mechanical  ventilation  (days)
Tracheostomy
Tracheostomy  date  (hospital  day)
2
Enteral  feeding  (hospital  day)
3
Gastrointestinal  bleeding
Hospital  stay  (days)
ICU  stay  (days)
17.9±23.8
20.6±27.7
18  (21)
17.7±9.5
4.7±5.2
15  (18)
34.4±36.2
23.6±28.0
12.1±6.8
13.3±12.6
5  (14)
21.2±11.7
3.9±2.7
1  (3)
39.0±21.9
19.4±15.4
22.3±30.5
26.3±34.3
13  (27)
16.3±8.7
5.6±7.0
14  (29)
30.9±44.0
26.8±34.6
0.029
0.019
NS
NS
NS
0.001
NS
NS
1Data  are  No.  (%)  or  means±SDs. 
2Data  came  from  patients  who  received  tracheostomy  (5  survivors  and  13  non-survivors).
3Data  came  from  patients  who  underwent  enteral  feeding  (37  survivors  and  32  non-survivors).
NS,  not  significant.
Table  3.  Clinical  parameters  of  patients  with  pneumonia  requiring  mechanical  ventilation
1
Variables
Relative  risk
(95%  confidence  interval)
p  value
PaCO2  <  45  mmHg
First  24-hour  urine  output  <  1.5  L
APACHE  II 
4.73  (2.16-10.33)
2.46  (1.29-4.66)
1.09  (1.03-1.16)
<0.001
0.006
0.004
APACHE  II,  Acute  Physiology  and  Chronic  Health  Evaluation  II.
Table  4.  Independent  factors  associated  with  mortality  according  to  multivariate  Cox  regression  analysis
Figure  2.  Survival  curve  during  the  hospital  stay  for  different 
levels  of  urine  output  during  the  first  24-hours.
Figure 1. Survival curve during the hospital stay for different initial 
levels  of  PaCO2.
of  less  than  1.5  L  (p=0.006,  RR=2.46,  95%  CI=1.29-4.66)  and  a 
high  APACHE  II  score  (p=0.004,  RR=1.09,  95%  CI=1.03-1.16) 
were  independently  associated  with  death  (Table  4,  Figure  1,  2).
DISCUSSION
The  mortality  in  our  series  that  was  attributable  to  severe 
CAP  requiring  mechanical  ventilation  was  56%.  This  rate  was 
slightly  higher  than  the  overall  mortality  rates  that  have  been 
quoted  for  similar  populations,  and  these  rates  have  ranged 
from  38%  to  55%
6, 8, 9, 12).  This  discrepancy  may  be  explained  by 
the  high  rate  (88%)  of  comorbidities  in  our  population;  more  that 
half  of  the  patients  had  two  concurrent  illnesses  or  more. 
However,  despite  this  possible  overestimation,  the  mortality 
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patients  who  required  mechanical  ventilation  was  undoubtedly 
high  and  this  is  a  challenge  for  physicians  in  the  ICU 
environment.
Cox  regression  analysis  identified  three  prognostic  factors, 
i.e.,  the  PaCO2,  the  first  24hr  urine  output  and  the  APACHE  II 
score  as  being  independently  associated  with  mortality  for  the 
patients  with  severe  CAP  that  required  mechanical  ventilation. 
Contrary  to  the  previous  investigations
3-8, 13),  it  was  interesting 
that  age,  the  PaO2/FiO2  ratio,  the  blood  urea  and  creatinine 
levels,  the  blood  pressure,  underlying  disease,  the  serum 
albumin  and  the  initial  antibiotic  therapy  were  not  found  to  be 
predictive  of  mortality. 
Of  note,  a  normal  to  lower  PaCO2  (<45  mmHg)  was  identified 
as  the  most  important  factor  associated  with  higher  mortality. 
This  finding  is  at  odds  with  the  findings  of  Afessa  et  al
14),  who 
found  that  a  high  PaCO2  level  was  associated  with  higher 
mortality  in  patients  with  pneumococcal  bacteremia.  Moreover, 
another  study  recently  demonstrated  that  in  patients  with  CAP, 
both  hypocapnia  (PaCO2  <32  mmHg)  and  hypercapnea  (PaCO2
≥45  mmHg)  increased  mortality  by  twofold  and  threefold, 
respectively,  compared  with  a  normal  PaCO2  (40  to  44 
mmHg)
15).  These  differences  may  be  due  to  differences  of  the 
study  populations.  In  our  present  study,  all  the  patients  received 
mechanical  ventilation,  whereas  the  previous  studies  also 
included  non-ventilated  patients.  However,  a  few  previous 
studies  support  our  findings.  Among  the  patients  with 
tuberculous  destroyed  lung  and  who  had  been  admitted  to  an 
ICU  because  of  acute  respiratory  failure,  a  higher  PaCO2  was 
found  to  be  a  predictor  of  improved  survival
16).  Further,  for 
patients  who  received  long-term  oxygen  therapy  due  to 
pulmonary  parenchymal  disease,  such  as  tuberculosis  sequelae 
or  interstitial  fibrosis,  a  lower  PaCO2  was  found  to  indicate 
poorer  survival
17).  Although  almost  40%  of  our  patients  had  a 
preexisting  respiratory  disease,  and  especially  COPD  or  a 
tuberculous  destroyed  lung,  no  difference  in  the  prevalence  of 
these  diseases  was  found  between  the  survivors  and 
non-survivors.
Ventilation  is  increased  in  patients  with  severe  pneumonia, 
and  this  is  primarily  due  to  lung  receptor  stimulation,  and 
probably  also  because  of  the  lactic  acidosis  that  arises  from 
tissue  hypoxia
18).  Despite  the  higher  PaCO2  in  the  survivors  of 
our  study  as  compared  to  the  non-survivors,  the  pH  levels  were 
similar  in  both  groups.  This  implies  that  non-survivors  with  a 
relatively  low  PaCO2  might  have  a  greater  burden  of  metabolic 
acid  than  that  of  the  survivors  with  a  high  PaCO2,  which  may 
have  increased  their  respiratory  drive
18).  Thus,  hypocapnia  and 
possibly  even  eucapnia  may  be  markers  of  sepsis
19).  It  is  also 
possible  that  a  lower  PaCO2  at  levels  similar  to  hypoxemia 
indicates  the  presence  of  a  more  advanced  diffusion  distur-
bances  or  a  more  advanced  ventilation-perfusion  mismatch
17). 
In  the  present  study,  the  alveolar-arterial  PO2  differences  were 
significantly  larger  in  the  non-survivors  than  in  the  survivors. 
This  data  suggests  that  the  ventilation-perfusion  mismatch, 
which  reflects  deranged  gas  exchange,  was  more  severe  in  the 
non-survivors.  On  the  other  hand,  emerging  evidence  has 
indicated  that  hypercapnia  in  itself  may  be  beneficial  for  patients 
with  respiratory  failure  and  inflammation
20).  Hypercapnia  causes 
a  complex  interaction  between  altered  cardiac  output,  hypoxic 
pulmonary  vasoconstriction  and  intrapulmonary  shunt,  which 
causes  a  net  increase  in  PaO2
21).  Because  hypercapnia 
increases  the  cardiac  output,  oxygen  delivery  is  increased 
throughout  the  body
21).  Regional  blood  flow,  including  the 
mesenteric  blood  flow,  is  also  increased
22),  and  so  this 
increases  oxygen  delivery  to  organs.  In  addition,  because 
hypercapnia  shifts  the  hemoglobin-oxygen  dissociation  curve  to 
the  right,  oxygen  delivery  to  tissues  is  further  increased
23). 
During  inflammatory  responses,  hypercapnia  may  tilt  the 
balance  towards  cell  salvage  at  the  tissue  level
24-26).  Therefore, 
our  results  may  indirectly  reflect  these  beneficial  effects  of 
hypercapnia  and  particularly  for  patients  with  pneumonia 
complicated  by  respiratory  failure.
A  decreased  first  24-hour  urine  output  was  the  second 
important  predictor  of  mortality,  which  is  in  agreement  with  the 
findings  of  El-solh  et  al
6).  Although  a  reduced  urine  out  may 
reflect  renal  dysfunction,  several  plasma  biochemical  markers 
have  been  used  to  diagnose  renal  dysfunction,  and  plasma 
creatinine  is  known  to  be  the  most  reliable  marker  of  renal 
function.  Thus,  a  large  number  of  studies  have  shown  that 
elevated  blood  urea  and/or  creatinine  were  highly  correlated 
with  a  poor  prognosis  for  patients  with  pneumonia
3, 4, 11). 
However,  in  the  present  study,  neither  the  blood  urea  nitrogen 
level  nor  the  creatinine  level  differed  between  the  survivors  and 
non-survivors,  and  they  were  not  correlated  with  the  first 
24-hour  urine  output.  Mechanical  ventilation  with  positive 
end-expiratory  pressure  (PEEP)  is  known  to  decrease  the  urine 
output  and  urinary  sodium  excretion  because  PEEP  reduces 
atrial  distension,  which  in  turn  reduces  the  release  of  atrial 
natriuretic  factor
27).  Some  investigators  have  consistently 
suggested  that  atrial  natriuretic  peptide  improves  pulmonary  gas 
exchange  by  reducing  the  extravascular  lung  water
28, 29).  In  other 
studies  on  patients  receiving  mechanical  ventilation,  a  higher 
peak  inspiratory  pressure
30)  and  a  higher  plateau  airway 
pressure  were  associated  with  increased  mortality
9).  In  the 
present  study,  the  non-survivors  had  slightly  higher  initial  PEEP 
levels  than  did  the  survivors  (the  data  is  not  shown).  However, 
since  we  do  not  have  exact  pressure  records  such  as 
auto-PEEP,  or  the  peak  and/or  plateau  airway  pressures,  we 
could  not  assume  that  the  intrathoracic  pressure,  rather  than  the 
renal  function  per  se  could  be  related  to  urine  output.
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II  score  despite  the  lack  of  a  difference  between  survivors  and 
non-survivors.  This  finding  concurs  with  those  of  others
3, 11). 
However,  contrary  to  the  majority  of  studies  on  the  subject
5, 7, 8, 12), 
markers  of  oxygenation,  i.e.,  PaO2,  PaO2/FiO2  and  an  alveolar- 
arterial  oxygen  difference,  were  not  found  to  be  significantly 
associated  with  mortality  in  the  present  study.  In  addition, 
neither  the  specific  pathogen  type  nor  the  initial  antibiotic 
therapy  was  found  to  affect  patient  mortality.  Moreover,  the 
tracheostomy  time  and  the  time  to  starting  enteral  feeding  were 
not  found  to  have  prognostic  implications.
The  present  study  has  several  limitations.  First,  it  was  a 
retrospective  study  that  was  conducted  in  the  ICU  of  a 
university  hospital,  and  some  data  such  as  airway  pressure  was 
not  available.  Second,  the  size  of  the  study  population  was 
relatively  small.  Third,  we  did  not  have  information  on  the 
specific  causes  of  death.  Fourth,  as  with  most  observational 
studies,  there  is  a  possibility  of  confounding  by  an 
unaccounted-for  factor.  However,  our  adjusted  results  were 
similar  to  our  unadjusted  results,  which  provide  some  assurance 
that  significant  confounding  was  unlikely.
In  the  present  study  and  in  most  other  studies  on  the 
subject,  severe  CAP  requiring  mechanical  ventilation  was  found 
to  have  high  mortality.  We  conclude  that  high  arterial  CO2  and 
a  large  first  24-hour  urine  output  favor  survival,  whereas  a  high 
APACHE  II  score  predicts  mortality.  Further  clinical  studies  with 
prospective  and  randomized  designs  should  be  undertaken  to 
confirm  these  results.  Moreover,  laboratory  investigations  may 
provide  deeper  insight  into  the  significance  of  the  PaCO2  level 
and  the  urine  output  for  pneumonia  associated  with  respiratory 
failure.
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